查詢結果分析
來源資料
相關文獻
- Transcatheter Closure of Secundum Atrial Septal Defect Using the Amplatzer Septal Occluder: Initial Results of a Single Medical Center in Taiwan
- Transcatheter Closure of Atrial Septal Defects with the Amplatzer Septal Occluder--Clinical Results
- Vasovagal Episode during Percutaneous Closure of Atrial Septal Defect: A Case Report
- Pike-Like Deformity of an Amplatzer® Septal Occluder: A Case Reoprt
- Sizing of Atrial Septal Defects by Intracardiac Echocardiography for Device Closures
- 安普拉茲中膈關閉器術後追蹤
- 應用即時三維心臟超音波測量心房中膈缺損大小之研究
- Combined Transcatheter Closure of Atrial Septal Defect and Patent Ductus Arteriosus: Report of Two Cases
- Transcatheter Closure of Atrial Septal Defect Guided by On-Line Transesophageal Echocardiography
- Satisfactory Right Ventricular Growth after Transannular Pulmonary Patch and Blalock-Taussig Shunt on Three Newborns with Pulmonary Atresia and Intact Ventricular Septum
頁籤選單縮合
題 名 | Transcatheter Closure of Secundum Atrial Septal Defect Using the Amplatzer Septal Occluder: Initial Results of a Single Medical Center in Taiwan=經心導管使用Amplatzer中膈關閉器關閉第二型心房中膈缺損:臺灣一醫學中心的初步結果 |
---|---|
作 者 | 林明志; 傅雲慶; 詹聖霖; 林維文; 朱光華; 丁紀台; 陳穎從; 遲景上; | 書刊名 | 臺灣兒科醫學會雜誌 |
卷 期 | 46:1 民94.01-02 |
頁 次 | 頁17-23+52 |
分類號 | 416.262 |
關鍵詞 | 心房中膈缺損; 心導管; 關閉器; Atrial septal defect; Catheterization; Device; |
語 文 | 英文(English) |
英文摘要 | The Amplatzer Septal Occluder (ASO) is the first and only device to receive full approval for clinical use in patients with secundum atrial septal defect (ASD) from the United States Food and Drug Administration. This study reports the device’s initial results in Taichung Veterans General Hospital, a tertiary medical center in central Taiwan. Between October 2001 and December 2004, 39 consecutive patients (31 females, 8 males) with secundum ASD underwent attempt at transcatheter closure using the ASO under general anesthesia and transesophageal echocardiographic guidance. Six patients were excluded due to deficient rims (2 patients), multiple ASDs (1 patient), too large a defect (1 patient), too small a defect (1 patient) and 1 patient with associated atrial flutter. A total of 33 patients (26 females, 7 males) underwent the device closure procedure. The median age was 10.6 years (range 3.1-57.5 years) and median weight was 42 kg (range 13.5-73 kg). The median Qp/Qs ratio was 2.12 (range 1.02-5.52). The median balloon stretched diameter of the defect by sizing plate was 16 mm (range 5-37 mm). A total of 33 devices (median size 17 mm, range 7-38 mm) were implanted in 33 patients. The median fluoroscopy time was 10.1 minutes (range 5.9-29 minutes) and the median procedure time was 55 minutes (range 30-105 minutes). Complications included asymptomatic device embolization to the right ventricle in 1 patient (surgical removal) and transient complete atrioventricular block in 1 patient. Follow-up echocardiography at 10 minutes, 24 hours, 1 month, 6 months, 1 year and 2 years after the procedure showed complete closure rates of 76% (25/33), 91% (30/33), 100% (32/32), 100% (22/22), 100% (22/22), and 100% (9/9), respectively. In conclusion, transcatheter closure of secundum ASD using the Amplatzer Septal Occluder is safe and effective, with a very low complication rate. |
本系統中英文摘要資訊取自各篇刊載內容。